Avidity Biosciences, Inc. (NASDAQ:RNA) Receives Consensus Rating of “Hold” from Analysts
Shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) have earned a consensus rating of “Hold” from the sixteen analysts that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, eleven have issued a hold recommendation, three have given a buy recommendation and one has […]
19 Sep 08:44 · The Markets Daily